TB-Bs1 is a first-in-class T-cell Engaging (TCE) bispecific antibody built on the DuoBody™ platform targeting ROR2. ROR2 is a receptor that has been shown to cause cancer cell proliferation and that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback